Tiny Stock Taking on Big Pharma

From Investing Trends | Ad

Big Pharma doesn't want to CURE depression. The longer we stay depressed, the more money they make. But one new company is changing all that.

And it's not too late to capitalize today

MYOV Insider Trading (Myovant Sciences)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $4,543,664.12

Myovant Sciences Insider Trading History Chart

Myovant Sciences Share Price & Price History

^$22.41

▲ +0.47 (2.14%)

As of 06/24/2021 12:36 PM ET

Days: 30 | 90 | 365

Why Are Billionaire Investors Betting On The 2021 Mental Health Revolution?

From Investing Trends | Ad

Investors say this little-known sector feels exactly like CBD did in 2017. This new technology is making investors like Peter Thiel very excited.

See How Early "Mental Health Revolution" Investors

Myovant Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/28/2021	Ferreira Juan Camilo Arjona	Insider	Sell	3,083	$24.00	$73,992.00	179,167
5/26/2021	Ferreira Juan Camilo Arjona	Insider	Sell	12,700	$24.23	$307,721.00	190,567
4/6/2021	Frank Karbe	Insider	Sell	11,080	$18.63	$206,420.40	152,390
4/6/2021	Matthew Lang	General Counsel	Sell	10,862	$18.62	$202,250.44	135,003
3/19/2021	Ferreira Juan Camilo Arjona	Insider	Sell	7,000	$24.17	$169,190.00	141,535
3/15/2021	Matthew Lang	General Counsel	Sell	30,000	$25.07	$752,100.00	175,865
1/28/2021	Frank Karbe	Insider	Sell	300	$24.00	$7,200.00	163,770
1/15/2021	Frank Karbe	Insider	Sell	750	$21.50	$16,125.00	164,220
12/28/2020	Frank Karbe	Insider	Sell	11,800	$30.00	$354,000.00	175,270
12/18/2020	Ferreira Juan Camilo Arjona	Insider	Sell	2,000	$26.00	$52,000.00	138,048
12/18/2020	Matthew Lang	General Counsel	Sell	10,000	$25.41	$254,100.00	155,865
12/15/2020	Ferreira Juan Camilo Arjona	Insider	Sell	7,000	$23.92	$167,440.00	143,048
12/10/2020	Ferreira Juan Camilo Arjona	Insider	Sell	10,000	$26.04	$260,400.00	146,048
12/10/2020	Matthew Lang	General Counsel	Sell	19,400	$25.20	$488,880.00	146,465
11/30/2020	Ferreira Juan Camilo Arjona	Insider	Sell	1,978	$23.65	$46,779.70	136,048
11/17/2020	Frank Karbe	Insider	Sell	750	$20.00	$15,000.00	164,220
11/13/2020	Frank Karbe	Insider	Sell	750	$20.00	$15,000.00	164,220
8/31/2020	Frank Karbe	Insider	Sell	24,800	$20.02	$496,496.00	149,333
8/31/2020	Matthew Lang	General Counsel	Sell	26,700	$20.05	$535,335.00	172,565
8/28/2020	Ferreira Juan Camilo Arjona	Insider	Sell	2,058	$20.01	$41,180.58	138,026
8/28/2020	Matthew Lang	General Counsel	Sell	2,700	$20.02	$54,054.00	145,965
8/26/2020	Matthew Lang	General Counsel	Sell	100	$20.00	$2,000.00	145,965
8/19/2020	Frank Karbe	Insider	Sell	700	$20.00	$14,000.00	164,170
8/19/2020	Matthew Lang	General Counsel	Sell	600	$20.00	$12,000.00	146,465
6/23/2020	Ferreira Juan Camilo Arjona	Insider	Sell	4,054	$20.00	$81,080.00	156,061
5/20/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	37,897	$12.58	$476,744.26
5/18/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	84,812	$11.93	$1,011,807.16
5/13/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	41,331	$12.38	$511,677.78
5/11/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	35,000	$12.78	$447,300.00
5/8/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	70,000	$12.89	$902,300.00
5/4/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	100,000	$11.48	$1,148,000.00
4/30/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	50,000	$12.08	$604,000.00
4/28/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	90,503	$11.78	$1,066,125.34
4/24/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	43,086	$12.15	$523,494.90
4/22/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	50,000	$11.93	$596,500.00
4/20/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	50,300	$11.82	$594,546.00
4/17/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	70,000	$10.76	$753,200.00
4/15/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	70,000	$10.48	$733,600.00
4/13/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	70,000	$9.81	$686,700.00
4/8/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	140,000	$9.55	$1,337,000.00
4/6/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	140,000	$7.84	$1,097,600.00
4/2/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	140,000	$8.08	$1,131,200.00
3/31/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	140,000	$7.92	$1,108,800.00
3/27/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	140,000	$7.71	$1,079,400.00
3/25/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	108,100	$7.60	$821,560.00
3/23/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	405,100	$7.49	$3,034,199.00
3/19/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	387,800	$7.49	$2,904,622.00
3/16/2020	Chemical Co. Ltd. Sumitomo	Major Shareholder	Buy	193,900	$7.25	$1,405,775.00
1/15/2020	Kim Sablich	Insider	Sell	4,840	$14.04	$67,953.60	59,690
12/30/2019	Frank Karbe	Insider	Sell	19,701	$15.55	$306,350.55	43,324
12/30/2019	Matthew Lang	General Counsel	Sell	19,018	$15.55	$295,729.90	34,597
12/18/2019	Kim Sablich	Insider	Sell	2,585	$16.22	$41,928.70	64,530
12/16/2019	Sciences Ltd. Roivant	Major Shareholder	Buy	170,000	$15.13	$2,572,100.00	44,895,145
12/4/2019	Sciences Ltd. Roivant	Major Shareholder	Buy	75,000	$17.06	$1,279,500.00	44,623,079
12/2/2019	Sciences Ltd. Roivant	Major Shareholder	Buy	179,193	$18.44	$3,304,318.92	44,623,079
11/25/2019	Sciences Ltd. Roivant	Major Shareholder	Buy	3,500,000	$15.00	$52,500,000.00	44,509,411
11/20/2019	Sciences Ltd. Roivant	Major Shareholder	Buy	121,906	$12.90	$1,572,587.40	40,887,505
6/12/2019	Kathleen Sebelius	Director	Buy	5,000	$8.96	$44,800.00	100
6/11/2019	Frank Karbe	Insider	Buy	8,000	$9.10	$72,800.00	8,000
6/4/2019	Andrew Lo	Major Shareholder	Buy	2,424,242	$8.25	$19,999,996.50	40,765,599
2/15/2019	Ferreira Juan Camilo Arjona	Insider	Sell	260	$21.15	$5,499.00	9,740

Insider Trading at Myovant Sciences?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Myovant Sciences and related companies.

SEC Filings (Institutional Ownership Changes) for Myovant Sciences (NYSE:MYOV)

31.79% of Myovant Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Myovant Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2021	Gladstone Institutional Advisory LLC	15,200	$0.31M	0.0%	N/A	0.017%
5/19/2021	Virtu Financial LLC	17,045	$0.35M	0.0%	N/A	0.019%
5/18/2021	Paloma Partners Management Co	18,131	$0.37M	0.0%	N/A	0.020%
5/18/2021	PFM Health Sciences LP	2,054,928	$42.29M	1.3%	+41.0%	2.246%
5/18/2021	Opaleye Management Inc.	249,800	$5.14M	0.8%	-63.4%	0.273%
5/18/2021	Point72 Asset Management L.P.	38,400	$0.79M	0.0%	N/A	0.042%
5/18/2021	Morgan Stanley	219,844	$4.52M	0.0%	-25.2%	0.240%
5/18/2021	Cormorant Asset Management LP	1,000,000	$20.58M	0.5%	-41.2%	1.093%
5/18/2021	Cubist Systematic Strategies LLC	13,624	$0.28M	0.0%	-59.4%	0.015%
5/17/2021	Royal Bank of Canada	1,480	$31K	0.0%	+211.6%	0.002%
5/17/2021	Captrust Financial Advisors	44,000	$0.91M	0.0%	+2.8%	0.048%
5/17/2021	Janus Henderson Group PLC	5,239,282	$107.83M	0.0%	+2.8%	5.727%
5/17/2021	Hennion & Walsh Asset Management Inc.	399,330	$8.22M	0.5%	N/A	0.437%
5/17/2021	Pinz Capital Management LP	5,900	$0.12M	0.0%	N/A	0.006%
5/17/2021	Goldman Sachs Group Inc.	383,087	$7.88M	0.0%	+186.4%	0.419%
5/14/2021	UBS Asset Management Americas Inc.	29,630	$0.61M	0.0%	-25.5%	0.033%
5/14/2021	Credit Suisse AG	32,290	$0.66M	0.0%	+17.4%	0.036%
5/14/2021	Quantbot Technologies LP	1,400	$28K	0.0%	N/A	0.002%
5/13/2021	QS Investors LLC	28,000	$0.58M	0.0%	N/A	0.031%
5/13/2021	Barclays PLC	18,536	$0.38M	0.0%	-60.1%	0.020%
5/13/2021	Pier Capital LLC	554,779	$11.42M	1.1%	+37.4%	0.611%
5/13/2021	Bourgeon Capital Management LLC	8,000	$0.17M	0.0%	+540.0%	0.009%
5/13/2021	Blackcrane Capital LLC	142,065	$2.92M	4.6%	+103.8%	0.156%
5/13/2021	Bank of New York Mellon Corp	41,125	$0.85M	0.0%	+70.7%	0.045%
5/13/2021	Citigroup Inc.	1,620	$33K	0.0%	+56.8%	0.002%
5/12/2021	Northern Trust Corp	89,634	$1.85M	0.0%	+782.0%	0.099%
5/12/2021	Geode Capital Management LLC	332,719	$6.85M	0.0%	N/A	0.366%
5/12/2021	JPMorgan Chase & Co.	12,296	$0.25M	0.0%	+289.6%	0.014%
5/12/2021	UBS Group AG	120,463	$2.48M	0.0%	-45.8%	0.133%
5/12/2021	Bellevue Group AG	5,194,039	$106.89M	1.1%	+8.1%	5.720%
5/11/2021	Acadian Asset Management LLC	187,263	$3.85M	0.0%	N/A	0.206%
5/11/2021	Synovus Financial Corp	77,790	$1.59M	0.0%	+21.0%	0.086%
5/11/2021	Rockefeller Capital Management L.P.	24,900	$0.51M	0.0%	N/A	0.027%
5/11/2021	Lord Abbett & CO. LLC	1,845,479	$37.98M	0.1%	-0.8%	2.032%
5/10/2021	Russell Investments Group Ltd.	6,600	$0.14M	0.0%	-91.9%	0.007%
5/10/2021	Integral Health Asset Management LLC	65,000	$1.34M	0.4%	+30.0%	0.072%
5/7/2021	BlackRock Inc.	955,352	$19.66M	0.0%	+432.0%	1.052%
5/7/2021	Cambridge Investment Research Advisors Inc.	38,655	$0.80M	0.0%	+12.1%	0.043%
5/7/2021	BNP Paribas Arbitrage SA	3,771	$78K	0.0%	+4,336.5%	0.004%
5/7/2021	Sowell Financial Services LLC	1,349	$26K	0.0%	-65.5%	0.001%
5/7/2021	Swiss National Bank	82,800	$1.70M	0.0%	+1.6%	0.091%
5/4/2021	Commonwealth Equity Services LLC	11,578	$0.24M	0.0%	+8.8%	0.013%
5/3/2021	Torray LLC	63,241	$1.30M	0.2%	+2.2%	0.070%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	3,917	$81K	0.0%	-29.0%	0.004%
4/27/2021	Harel Insurance Investments & Financial Services Ltd.	4,000	$0.28M	0.0%	N/A	0.004%
4/12/2021	Trilogy Capital Inc.	10,979	$0.23M	0.0%	N/A	0.012%
3/9/2021	tru Independence LLC	700	$19.33M	0.0%	N/A	0.001%
3/2/2021	Norges Bank	1,527,540	$42.19M	0.0%	N/A	1.682%
3/1/2021	UBS Asset Management Americas Inc.	39,793	$1.10M	0.0%	+12.6%	0.044%
2/24/2021	Bank Julius Baer & Co. Ltd Zurich	1,086	$30K	0.0%	N/A	0.001%
2/19/2021	JPMorgan Chase & Co.	3,156	$87K	0.0%	+17.1%	0.003%
2/18/2021	Truist Financial Corp	126,000	$3.48M	0.0%	+223.1%	0.139%
2/17/2021	Voloridge Investment Management LLC	101,442	$2.80M	0.0%	N/A	0.112%
2/16/2021	Highline Capital Management L.P.	67,100	$1.85M	0.9%	N/A	0.074%
2/16/2021	Squarepoint Ops LLC	28,547	$0.79M	0.0%	+114.7%	0.032%
2/16/2021	Tri Locum Partners LP	40,910	$1.13M	0.4%	N/A	0.045%
2/16/2021	Morgan Stanley	294,008	$8.12M	0.0%	+81.0%	0.325%
2/16/2021	Tudor Investment Corp Et Al	29,846	$0.82M	0.0%	N/A	0.033%
2/16/2021	Captrust Financial Advisors	42,790	$1.18M	0.0%	+6.9%	0.047%
2/16/2021	Pier Capital LLC	403,839	$11.15M	1.2%	+33.4%	0.446%
2/16/2021	Janus Henderson Group PLC	5,098,315	$140.82M	0.1%	+28.6%	5.628%
2/16/2021	Apis Capital Advisors LLC	130,000	$3.59M	3.5%	N/A	0.143%
2/12/2021	Raymond James Financial Services Advisors Inc.	8,932	$0.25M	0.0%	N/A	0.010%
2/12/2021	Credit Suisse AG	27,513	$0.76M	0.0%	-50.2%	0.030%
2/12/2021	Virtus ETF Advisers LLC	12,236	$0.34M	0.1%	-33.2%	0.014%
2/11/2021	Synovus Financial Corp	64,282	$1.78M	0.0%	+8.4%	0.071%
2/11/2021	Trexquant Investment LP	29,428	$0.81M	0.1%	N/A	0.032%
2/11/2021	Barclays PLC	46,500	$1.28M	0.0%	-34.7%	0.051%
2/11/2021	Handelsbanken Fonder AB	11,200	$0.31M	0.0%	N/A	0.012%
2/11/2021	Oppenheimer & Co. Inc.	7,450	$0.21M	0.0%	N/A	0.008%
2/10/2021	Renaissance Technologies LLC	111,700	$3.09M	0.0%	-47.0%	0.123%
2/10/2021	Belvedere Trading LLC	14,793	$0.41M	0.0%	N/A	0.016%
2/10/2021	Blackcrane Capital LLC	69,695	$1.93M	3.8%	N/A	0.077%
2/9/2021	Wells Fargo & Company MN	23,611	$0.65M	0.0%	+64.2%	0.026%
2/9/2021	Bank of New York Mellon Corp	24,094	$0.67M	0.0%	+2.6%	0.027%
2/9/2021	Lord Abbett & CO. LLC	1,860,497	$51.39M	0.1%	+1.9%	2.054%
2/8/2021	Russell Investments Group Ltd.	81,684	$2.25M	0.0%	-27.9%	0.090%
2/5/2021	Letko Brosseau & Associates Inc.	63,204	$1.75M	0.0%	+26.4%	0.070%
2/5/2021	BlackRock Inc.	179,594	$4.96M	0.0%	-2.5%	0.198%
2/4/2021	Cambridge Investment Research Advisors Inc.	34,490	$0.95M	0.0%	+1.8%	0.038%
2/4/2021	GSA Capital Partners LLP	12,054	$0.33M	0.1%	-15.8%	0.013%
2/2/2021	California Public Employees Retirement System	96,397	$2.66M	0.0%	-1.8%	0.106%
2/2/2021	Evolution Wealth Advisors LLC	140,227	$3.87M	0.9%	+95.5%	0.155%
2/1/2021	Victory Capital Management Inc.	1,709,225	$47.21M	0.1%	-4.2%	1.887%
1/29/2021	Creative Planning	20,900	$0.58M	0.0%	+18.1%	0.023%
1/29/2021	Bourgeon Capital Management LLC	1,250	$35K	0.0%	-86.0%	0.001%
1/27/2021	Lindbrook Capital LLC	1,000	$28K	0.0%	-80.0%	0.001%
1/27/2021	Calamos Advisors LLC	125,649	$3.47M	0.0%	+22.5%	0.139%
1/27/2021	CWM LLC	1,205	$33K	0.0%	N/A	0.001%
1/20/2021	Concentrum Wealth Management	14,610	$0.40M	0.3%	+17.0%	0.016%
1/19/2021	Rhenman & Partners Asset Management AB	200,000	$5.52M	0.5%	-47.4%	0.221%
1/13/2021	Sowell Financial Services LLC	3,913	$0.11M	0.0%	+215.8%	0.004%
11/17/2020	PFM Health Sciences LP	628,272	$8.83M	0.4%	N/A	0.694%
11/17/2020	Twinbeech Capital LP	18,178	$0.26M	0.1%	N/A	0.020%
11/17/2020	Captrust Financial Advisors	40,040	$0.56M	0.0%	+66.6%	0.044%
11/16/2020	Cubist Systematic Strategies LLC	11,336	$0.16M	0.0%	-45.1%	0.013%
11/16/2020	Squarepoint Ops LLC	13,296	$0.19M	0.0%	-36.5%	0.015%
11/16/2020	ExodusPoint Capital Management LP	40,424	$0.57M	0.0%	-7.1%	0.045%
11/16/2020	Engineers Gate Manager LP	43,387	$0.61M	0.0%	+133.8%	0.048%
11/16/2020	Amia Capital LLP	25,111	$0.35M	0.4%	-7.2%	0.028%

Data available starting January 2016

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, for the treatment of female infertility as part of assisted reproduction and is under phase 2 clinical trial. Myovant Sciences Ltd. has collaboration with Pfizer Inc. to develop and commercialize relugolix in oncology and women's health. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was incorporated in 2016 and is based in London, the United Kingdom. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd.

Today's Range

Now: $22.41

$22.01

$22.54

50 Day Range

MA: $21.39

$17.49

$24.56

52 Week Range

Now: $22.41

$13.42

$30.90

Volume

4,273 shs

Average Volume

896,154 shs

Market Capitalization

$2.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.88

Who are the company insiders with the largest holdings of Myovant Sciences?

Myovant Sciences' top insider shareholders include:

Sciences Ltd Roivant (Major Shareholder)
Ferreira Juan Camilo Arjona (Insider)
Matthew Lang (General Counsel)
Frank Karbe (Insider)
Kim Sablich (Insider)
Chemical Co Ltd Sumitomo (Major Shareholder)

Who are the major institutional investors of Myovant Sciences?

Myovant Sciences' top institutional shareholders include:

Janus Henderson Group PLC — 5.73%
Bellevue Group AG — 5.72%
PFM Health Sciences LP — 2.25%
Lord Abbett & CO. LLC — 2.03%
Cormorant Asset Management LP — 1.09%
BlackRock Inc. — 1.05%

Which institutional investors are selling Myovant Sciences stock?

In the previous quarter, MYOV stock was sold by these institutional investors:

Cormorant Asset Management LP
Opaleye Management Inc.
UBS Group AG
Russell Investments Group Ltd.
Morgan Stanley
Barclays PLC
Cubist Systematic Strategies LLC
Lord Abbett & CO. LLC

Within the previous year, company insiders that have sold Myovant Sciences company stock include:

Sciences Ltd Roivant (Major Shareholder)
Ferreira Juan Camilo Arjona (Insider)
Matthew Lang (General Counsel)

Which institutional investors are buying Myovant Sciences stock?

Within the last quarter, MYOV stock was bought by institutional investors including:

BlackRock Inc.
PFM Health Sciences LP
Hennion & Walsh Asset Management Inc.
Bellevue Group AG
Geode Capital Management LLC
Goldman Sachs Group Inc.
Acadian Asset Management LLC
Pier Capital LLC

In the previous year, these company insiders have bought Myovant Sciences stock:

Sciences Ltd Roivant (Major Shareholder)
Ferreira Juan Camilo Arjona (Insider)

Why Are Billionaire Investors Betting On The 2021 Mental Health Revolution?

From Investing Trends | Ad

Investors say this little-known sector feels exactly like CBD did in 2017. This new technology is making investors like Peter Thiel very excited.

See How Early "Mental Health Revolution" Investors